BCL2 and breast carcinoma: Previous studies (in vitro and in vivo) have suggested that upregulating of Bcl‐2 in breast cancer cells promotes metastasis to the lung in mice by the EMT process and triggers resistance to chemotherapy (PD168393, a specific inhibitor of EGFR; AG490, an inhibitor of JAK2).217, 218